AEON Biopharma (AEON) Long-Term Deferred Tax (2020 - 2022)
AEON Biopharma (AEON) posted Long-Term Deferred Tax of $642542.0 for Q4 2022, up 64.83% sequentially from $389814.0 in Q4 2021, and up 64.83% YoY from $389814.0 in Q4 2021.
AEON Biopharma (AEON) Long-Term Deferred Tax (2020 - 2022) Analysis & Trends
AEON Biopharma has reported Long-Term Deferred Tax for 3 years, with the latest figure at $642542.0 in Q4 2022.
- Quarterly Long-Term Deferred Tax rose 64.83% year-over-year to $642542.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $642542.0 (up 64.83% YoY) and the FY2022 annual result came in at $642542.0, up 64.83% from the prior year.
- Long-Term Deferred Tax grew to $642542.0 in Q4 2022 per AEON's latest filing, from $389814.0 in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $642542.0 in Q4 2022 and troughed at $81000.0 in Q4 2020.
- A 3-year average of $371118.7 and a median of $389814.0 in 2021 frame the typical range for Long-Term Deferred Tax.
- The sharpest annual moves came in 2021 and 2022: Long-Term Deferred Tax soared 381.25% in 2021, then jumped 64.83% in 2022.
- Over 3 years, Long-Term Deferred Tax stood at $81000.0 in 2020, then jumped by 381.25% to $389814.0 in 2021, then jumped by 64.83% to $642542.0 in 2022.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $642542.0, $389814.0, and $81000.0 for Q4 2022, Q4 2021, and Q4 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | AEON Biopharma | 10.06 Mn | 6.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 642,542.00 |
| Dec 31, 2021 | 389,814.00 |
| Dec 31, 2020 | 81,000.00 |